Pricing and Reimbursement
Our deep understanding of the global pricing and reimbursement systems, national, regional and local payers’ needs, combined with unique access to key stakeholders, including payers, clinicians and patients, enables us to develop actionable programmes to optimise pricing and reimbursement for pharmaceutical, biotechnology, diagnostic and medical device products at all stages of development and in all key geographic markets.
Early stage pricing research
- Research investment and clinical development decision making
- In/out-licensing evaluation
- Price-performance considerations
- Early stage health economic modelling
- Go / no go decisions
- Resource allocation
Pre-launch pricing strategy
- Optimal positioning
- International considerations – country specific, pricing corridors and IPR
- Reimbursement & contracting strategy
- Revenue forecasting
Launch
- Launch price
- Negotiation strategies
- Risk sharing and patient access schemes
Post-launch
- Competitive pricing decisions
- Line or indication extensions
- Life-cycle
- Loss of exclusivity scenarios
- OTC potential
For further information please contact us now.
